Tuberculosis in children: New diagnostic blood tests

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 21, Issue 4, 2010, Pages

  Kakkar, Fatima ^f   Allen, Upton D ^f   Ling, D ^b   Pai, M ^b   Kitai, Ian C ^a,f   Bortolussi, Robert ^a   Finlay, Jane ^b   McDonald, Jane C ^c   Onyett, Heather ^d   Robinson, Joan L ^b   Rousseau Harsany, Élisabeth ^e   Hui, Charles P S ^g   Le Saux, Nicole ^b   Pickering, Larry ^h   Salvadori, Marina I ^b   Kellner, James ^f   MacDonald, Noni E ^a   Moore, Dorothy L ^c  

^a IWK HEALTH CENTRE   (Canada)

^b Montreal Children's Hospital ^*

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^h CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

Diagnosis; Interferon gamma release assay; Paediatrics; Tuberculosis

Indexed keywords

GAMMA INTERFERON; GLUCOCORTICOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASSAY; CANADA; CHEMOPROPHYLAXIS; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FALSE POSITIVE RESULT; FOOD AND DRUG ADMINISTRATION; GRANULOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INTERFERON GAMMA RELEASE ASSAY; INTERFERON PRODUCTION; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NOTE; RISK FACTOR; SILICOSIS; TUBERCULIN TEST;

EID: 79953241567     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/129616     Document Type: Note

References (32)

1. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis 2008;8:498-510. (Pubitemid 352001412)
2. Shingadia D, Novelli V. Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis 2003;3:624-32. (Pubitemid 37210226)
3. Marais BJ, Pai M. Recent advances in the diagnosis of childhood tuberculosis. Arch Dis Child 2007;92:446-52. (Pubitemid 46698145)
4. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: Old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-90. (Pubitemid 43726888)
5. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002;6:1038-45. (Pubitemid 36054956)
6. Donald PR. Childhood tuberculosis: Out of control? Curr Opin Pulm Med 2002;8:178-82.
7. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Inf Dis 1993;17:968-75. (Pubitemid 23358739)
8. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970;26:28-106.
9. Public Health Agency of Canada. Canadian Tuberculosis Standards. 〈http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbstand07-eng.php〉 (Accessed on September 15, 2010).
10. Madhi SA, Gray GE, Huebner RE, Sherman G, McKinnon D, Pettifor JM. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test, and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J 1999;18:800-5. (Pubitemid 29428536)
11. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-104.
12. Fine PE, Sterne JA, Pönnighaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994;344:1245-9. (Pubitemid 24334679)
13. Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998;144:3195-203. (Pubitemid 28515598)
14. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect Dis 2007;7:428-38. (Pubitemid 46779096)
15. QuantiFERON-TB-Gold In-Tube: Technical information. 〈www.cellestis. com/IRM/content/aust/qtfproducts-tbgoldintube-techinfo.html〉 (Accessed on September 15, 2010).
16. T.SPOT-TB. 8-well strip plate format (TB.300). Package insert for Canada. 〈www.oxfordimmunotec.com/CANpageinsert〉 (Accessed on September 15, 2010).
17. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008;149:177-84.
18. Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007;45:322-8. (Pubitemid 47101028)
19. Dogra S, Narang P, Mendiratta DK, et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect 2007;54:267-76. (Pubitemid 46238165)
20. Okada K, Mao TE, Mori T, et al. Perfomance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 2008;136:1179-87.
21. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: A prospective community-based study. Lancet 2005;366:1433-51.
22. Tsiouris SJ, Austin J, Toro P, et al. Results of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis 2006;10:939-41. (Pubitemid 44197857)
23. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In- Tube test. Pediatrics 2009;123:30-7.
24. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008;149:777-87.
25. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204.
26. American Academy of Pediatrics. Red Book: 2009 Report of the Committee on Infectious Diseases. 〈http://aapredbook.aappublications.org/current. dtl〉 (Accessed on September 15, 2010).
27. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: A prospective cohort study. Lancet 2004;364:2196-203. (Pubitemid 40018449)
28. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007;12:88-92. (Pubitemid 44968205)
29. Nicol MP, Davies MA, Wood K, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009;123:38-43.
30. Canadian Tuberculosis Committee. Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007;33:1-18.
31. Canadian Tuberculosis Committee. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008;34:1-13.
32. Canadian Tuberculosis Committee. Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection - 2010 update. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2010;36:ACS-5:1-13.